Enrolling by invitationPhase 4NCT07005726
BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa
Studying Diphtheria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bandim Health Project
- Principal Investigator
- Christine Stabell Benn, MD, PhD, DMScBandim Health Project and Danish Institute for Advanced Science, University of Southern Denmark
- Intervention
- BCG Vaccine(biological)
- Enrollment
- 6000 enrolled
- Eligibility
- All sexes
- Timeline
- 2025 – 2030
Study locations (1)
- Bandim Health Project, Bissau, Guinea-Bissau
Collaborators
University of Southern Denmark · Radboud University Medical Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07005726 on ClinicalTrials.govOther trials for Diphtheria
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07203755Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined VaccineCanSino Biologics Inc.
- RECRUITINGPHASE4NCT07097012Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in PregnancyCanadian Immunization Research Network
- RECRUITINGPHASE3NCT07112144Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical TrialChangchun BCHT Biotechnology Co.
- RECRUITINGPHASE1, PHASE2NCT06997627A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy AdultsGC Biopharma Corp
- RECRUITINGNANCT06815250Enhancing Maternal Vaccine Knowledge and Uptake: the InTroDuce-Programme TrialUniversiti Putra Malaysia
- RECRUITINGPHASE2, PHASE3NCT06947499A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary SeriesLG Chem
- ACTIVE NOT RECRUITINGPHASE3NCT06857370Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined VaccineCanSino Biologics Inc.
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT06708286A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)CanSino Biologics Inc.